申请人:Fisons Corporation
公开号:US05502164A1
公开(公告)日:1996-03-26
Compounds of formula I, ##STR1## wherein M is Met, DMet, MeMet, MetO, Ahx, DAhx, MeAhx, Leu, MeLeu, Pro, Ile, MeIle, Ala or Lys, G is Gly, DAla, Pro, Ala, .beta.Ala or Sar; W is Trp, MeTrp, Ala or Nal; X is Met, MeMet, MetO, Ahx, MeAhx, Leu, MeLeu, Pro, Ile, MeIle, Ala, Phe, Lys or Lys(R.sup.8); J is Asp, DAsp, MeAsp, Asp(OBn), Ala or MeDAsp; F.sup.1 is (S)--NH, (R)--NH, (S)--R.sup.1 N or (R)--R.sup.2 N; F.sup.2 is H, Cl, I, Br, F, NO.sub.2, NH.sub.2, R.sup.3 or OR.sup.4 ; Z is NH.sub.2, NHR.sup.5 or NR.sup.5 R.sup.6 ; R.sup.1, R.sup.2, R.sup.3, R.sup.5 and R.sup.6 are alkyl C.sub.1-6 ; R.sup.4 is H or alkyl C.sub.1-4 ; R.sup. is OH or OSO.sub.3 H; and pharmaceutically acceptable derivatives thereof; are useful as therapeutic agents, in particular in the inhibition of feeding.
化合物的公式I,其中M是Met,DMet,MeMet,MetO,Ahx,DAhx,MeAhx,Leu,MeLeu,Pro,Ile,MeIle,Ala或Lys,G是Gly,DAla,Pro,Ala,β.Ala或Sar; W是Trp,MeTrp,Ala或Nal; X是Met,MeMet,MetO,Ahx,MeAhx,Leu,MeLeu,Pro,Ile,MeIle,Ala,Phe,Lys或Lys(R.sup.8); J是Asp,DAsp,MeAsp,Asp(OBn),Ala或MeDAsp; F.sup.1是(S)-NH,(R)-NH,(S)-R.sup.1 N或(R)-R.sup.2 N; F.sup.2是H,Cl,I,Br,F,NO.sub.2,NH.sub.2,R.sup.3或OR.sup.4; Z是NH.sub.2,NHR.sup.5或NR.sup.5R.sup.6; R.sup.1,R.sup.2,R.sup.3,R.sup.5和R.sup.6是C.sub.1-6烷基; R.sup.4是H或C.sub.1-4烷基; R.sup.是OH或OSO.sub.3H;以及其药学上可接受的衍生物;在治疗方面是有用的,特别是在抑制摄食方面。